Literature DB >> 15040016

Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas.

Jun-Qiang Chen1, Wen-Hua Zhan, Yu-Long He, Jun-Sheng Peng, Jian-Ping Wang, Shi-Rong Cai, Jin-Ping Ma.   

Abstract

AIM: To explore the expression of heparanase gene, CD44v6, MMP-7 and nm23 proteins in human gastric carcinoma as well as their relationship with the clinicopathological factors.
METHODS: Reverse transcription polymerase chain reaction (RT-PCR) was used to measure the expressions of heparanase mRNA in 43 human gastric carcinomas and 10 adjacent normal gastric tissues. Streptavidin-peroxidase (S-P) two step method was used to measure the immunohistochemical expression of CD44v6, MMP-7 and nm23 protein in 43 human gastric carcinomas.
RESULTS: The expression of heparanase gene was positive in 29 cases of gastric cancer with a positive rate of 67.4%, which was significantly higher than those in adjacent normal gastric tissues (P<0.05). The heparanase mRNA expression was significantly related to advanced stage of disease, serosal infiltration, lymph node metastasis and size of tumors (P<0.05), but not related to tumor location, gross and histological types of the cancer, peritoneal dissemination and liver metastasis (P>0.05). The positive rate of CD44v6, nm23 and MMP-7 proteins was 76.7%, 37.2% and 60.5%, respectively. The CD44v6 protein expression was significantly related to serosal infiltration, lymph node metastasis and TNM stage of disease (P<0.05). The nm23 protein expression was significantly related to the tumor gross appearance, lymph node and peritoneal metastasis (P<0.05). The MMP-7 protein expression was significantly related to serosal infiltration and TNM stage of disease (P<0.05). In an attempt to measure the association between these agents, we found that the expression of heparanase mRNA had significantly negative correlation with the expression of CD44v6 and MMP-7 protein (P<0.05), the expression of MMP-7 protein had significantly positive correlation with the expression of CD44v6 protein (r=0.568, P<0.05), the expression of MMP-7 protein had no correlation with the expression of nm23 protein (P>0.05), and the expression of nm23 protein had no correlation with the expression of CD44v6 protein (P>0.05).
CONCLUSION: Despite their different mechanisms of action, heparanase, CD44v6 and nm23 may play important roles in the invasive infiltration and lymph node metastasis in gastric carcinomas. Instead of metastatic spreading, MMP-7 may be just related to the invasion of gastric carcinomas. However, co-detection of these factors may be important to predict metastatic spreading in such patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15040016      PMCID: PMC4727025          DOI: 10.3748/wjg.v10.i6.776

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma.

Authors:  O N El-Assal; A Yamanoi; T Ono; H Kohno; N Nagasue
Journal:  Clin Cancer Res       Date:  2001-05       Impact factor: 12.531

Review 2.  CD44 and its partners in metastasis.

Authors:  Serge Jothy
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

3.  Heparanase gene expression and metastatic potential in human gastric cancer.

Authors:  K Endo; U Maejara; H Baba; E Tokunaga; T Koga; Y Ikeda; Y Toh; S Kohnoe; T Okamura; M Nakajima; K Sugimachi
Journal:  Anticancer Res       Date:  2001 Sep-Oct       Impact factor: 2.480

4.  Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis.

Authors:  M D Hulett; C Freeman; B J Hamdorf; R T Baker; M J Harris; C R Parish
Journal:  Nat Med       Date:  1999-07       Impact factor: 53.440

5.  Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer.

Authors:  Yutaka Yonemura; Yoshio Endou; Hideto Fujita; Sachio Fushida; Etsurou Bandou; Keizou Taniguchi; Kouichi Miwa; Kazuo Sugiyama; Takuma Sasaki
Journal:  Gastric Cancer       Date:  2000-09-29       Impact factor: 7.370

6.  Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase.

Authors:  D Marchetti; J Li; R Shen
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

7.  Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis.

Authors:  Akio Yamaguchi; Takanori Goi; Jiren Yu; Yasuo Hirono; Makoto Ishida; Atsushi Iida; Toshihisa Kimura; Kazuo Takeuchi; Kanji Katayama; Kazuo Hirose
Journal:  J Surg Oncol       Date:  2002-04       Impact factor: 3.454

Review 8.  The human Nm23/nucleoside diphosphate kinases.

Authors:  M L Lacombe; L Milon; A Munier; J G Mehus; D O Lambeth
Journal:  J Bioenerg Biomembr       Date:  2000-06       Impact factor: 2.945

9.  Co-expression of CD44v3 and heparanase is correlated with metastasis of human colon cancer.

Authors:  Hiroki Kuniyasu; Yoshitomo Chihara; Tadahiko Kubozoe; Tadateru Takahashi
Journal:  Int J Mol Med       Date:  2002-09       Impact factor: 4.101

10.  Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma.

Authors:  J Rohloff; J Zinke; K Schoppmeyer; A Tannapfel; H Witzigmann; J Mössner; C Wittekind; K Caca
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

View more
  19 in total

1.  Role of cancer stem cell marker CD44 in gastric cancer: a meta-analysis.

Authors:  Wei Wang; Li-Ping Dong; Ning Zhang; Cheng-Hai Zhao
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancer.

Authors:  Tineke E Buffart; Beatriz Carvalho; Nicole C T van Grieken; Wessel N van Wieringen; Marianne Tijssen; Elma Meershoek-Klein Kranenbarg; Henk M W Verheul; Heike I Grabsch; Bauke Ylstra; Cornelis J H van de Velde; Gerrit A Meijer
Journal:  Oncologist       Date:  2012-04-24

3.  Relationship of serum MMP-7 levels for colorectal cancer: a meta-analysis.

Authors:  Xiao-Jing Xing; Xiao-Hu Gu; Tian-Fei Ma
Journal:  Tumour Biol       Date:  2014-07-25

4.  Matrix metalloproteinase-7 mRNA and protein expression in gastric carcinoma: a meta-analysis.

Authors:  Zi-Wen Long; Jiang-Li Wang; Ya-Nong Wang
Journal:  Tumour Biol       Date:  2014-08-15

Review 5.  Gastric cancer stem cells: evidence, potential markers, and clinical implications.

Authors:  Daniel Brungs; Morteza Aghmesheh; Kara L Vine; Therese M Becker; Martin G Carolan; Marie Ranson
Journal:  J Gastroenterol       Date:  2015-10-01       Impact factor: 7.527

6.  Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma.

Authors:  Zhen-Dong Gu; Ke-Neng Chen; Ming Li; Jin Gu; Ji-You Li
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

7.  Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasias.

Authors:  Constantine S Mitsiades; Cecile Rouleau; Cinara Echart; Krishna Menon; Beverly Teicher; Maria Distaso; Antonio Palumbo; Mario Boccadoro; Kenneth C Anderson; Massimo Iacobelli; Paul G Richardson
Journal:  Clin Cancer Res       Date:  2009-02-15       Impact factor: 12.531

8.  Heparanase is overexpressed in lung cancer and correlates inversely with patient survival.

Authors:  Esti Cohen; Ilana Doweck; Inna Naroditsky; Ofer Ben-Izhak; Ran Kremer; Lael A Best; Israel Vlodavsky; Neta Ilan
Journal:  Cancer       Date:  2008-09-01       Impact factor: 6.860

Review 9.  Exosome-mediated peritoneal dissemination in gastric cancer and its clinical applications.

Authors:  Kai-Bo Chen; Jian Chen; Xiao-Li Jin; Yi Huang; Qiu-Ming Su; Li Chen
Journal:  Biomed Rep       Date:  2018-04-19

10.  Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance.

Authors:  Kamran Ghaffarzadehgan; Mostafa Jafarzadeh; Hamid Reza Raziee; Hamid Reza Sima; Ehsan Esmaili-Shandiz; Hanieh Hosseinnezhad; Ali Taghizadeh-Kermani; Omeed Moaven; Maryam Bahrani
Journal:  World J Gastroenterol       Date:  2008-11-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.